Speciality European Pharma (Mitem) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 2

Speciality European Pharma (Mitem) General Information

Description

Rights of a bladder cancer product.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • London
  • England, United Kingdom
Primary Industry
Buildings and Property
Other Industries
Drug Delivery
Acquirer
Corporate Office
  • London
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Speciality European Pharma (Mitem) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Speciality European Pharma (Mitem)‘s full profile, request access.

Request a free trial

Speciality European Pharma (Mitem) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Speciality European Pharma (Mitem)‘s full profile, request access.

Request a free trial

Speciality European Pharma (Mitem) FAQs

  • Where is Speciality European Pharma (Mitem) headquartered?

    Speciality European Pharma (Mitem) is headquartered in London, United Kingdom.

  • What industry is Speciality European Pharma (Mitem) in?

    Speciality European Pharma (Mitem)’s primary industry is Buildings and Property.

  • Is Speciality European Pharma (Mitem) a private or public company?

    Speciality European Pharma (Mitem) is a Private company.

  • What is Speciality European Pharma (Mitem)’s current revenue?

    The current revenue for Speciality European Pharma (Mitem) is .

  • Who are Speciality European Pharma (Mitem)’s investors?

    Contura has invested in Speciality European Pharma (Mitem).

  • When was Speciality European Pharma (Mitem) acquired?

    Speciality European Pharma (Mitem) was acquired on 27-Apr-2017.

  • Who acquired Speciality European Pharma (Mitem)?

    Speciality European Pharma (Mitem) was acquired by Substipharm.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process